To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The hedge fund has met with ...
20h
Once with 360 employees, Theravance Biopharma's latest cuts to whittle workforce to fewer than 50
This company put everything into one drug. Now it's cutting half of staff. Here's more on how Theravance Biopharma will close its research unit, cut staff below 50 and explore a sale after a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results